Back to VA VANGUARD CAPITAL MANAGEMENT LLC

KYTXKYTX
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in KYVERNA THERAPEUTICS INC

Yes. Vanguard Capital Management holds 1,897,451 shares of KYTX (Kyverna Therapeutics), worth $16.9M, as of its Q2 2026 13F filing. It increased the position by 114,109 shares (+6.4%) from Q1 2026. Vanguard Capital Management has held KYTX in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$16.9M

Current Shares

1.9M

Total Value Change

+$1.5M

Total Shares Change

+114,109

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+6.4%
$16.9M0.0%$8.91
30
2026-Q1
First report
1.8M
-
$15.4M0.0%$8.63
0

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used